Division of Vascular and Endovascular Surgery, University of Texas Health Science, Houston, Texas.
Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, Minnesota.
Ann Surg. 2022 Dec 1;276(6):e1028-e1034. doi: 10.1097/SLA.0000000000004624. Epub 2021 Jan 7.
The aim of this study was to analyze the outcomes of a standardized protocol using routine CSFD, neuromonitoring, LL reperfusion, and selective TASP to prevent SCI during F-BEVAR.
SCI is to be the most devastating complication for the patient, family, and surgeon, with impact on patient's quality of life and long-term prognosis. An optimal standardized protocol may be used to improve outcomes.
Patients enrolled in a prospective, nonrandomized single-center study between 2013 and 2018. A SCI prevention protocol was used for TAAAS or complex abdominal aneurysms with ≥5-cm supraceliac coverage including CSFD, neuromonitoring, LL reperfusion, and selective TASP. Endpoints included mortality and rates of SCI.
SCI prevention protocol was used in 170 of 232 patients (73%) treated by F-BEVAR. Ninety-one patients (55%) had changes in neuromonitoring, which improved with maneuvers in all except for 9 patients (10%) who had TASP. There was one 30-day or in-hospital mortality (0.4%). Ten patients (4%) developed SCIs including in 1% (1/79) of patients with normal neuromonitoring and 10% (9/91) of those who had decline in neuromonitoring ( P = 0.02). Permanent paraplegia occurred in 2 patients (1%). Factors associated with SCI included total operating time (odds ratio 1.5, 95% confidence interval 1.1-2.2, P = 0.02) and persistent changes in neuromonitoring requiring TASP (odds ratio 15.7, 95% confidence interval 2.9-86.2, P = 0.001).
This prospective nonrandomized study using a standardized strategy to prevent SCI was associated with low incidence of the SCI during F-BEVAR. Permanent paraplegia occurred in 1%.
本研究旨在分析使用常规 CSFD、神经监测、下肢再灌注和选择性 TASP 预防 F-BEVAR 中 SCI 的标准化方案的结果。
SCI 是对患者、家属和外科医生最具破坏性的并发症,对患者的生活质量和长期预后有影响。优化的标准化方案可能会改善结果。
2013 年至 2018 年间,患者纳入前瞻性、非随机单中心研究。对于 TAAAS 或≥5cm 腹腔干以上覆盖的复杂腹主动脉瘤,采用 SCI 预防方案,包括 CSFD、神经监测、下肢再灌注和选择性 TASP。终点包括死亡率和 SCI 发生率。
170/232 例(73%)行 F-BEVAR 治疗的患者采用了 SCI 预防方案。91 例(55%)患者的神经监测发生变化,除 9 例(10%)患者需要 TASP 外,所有患者均通过操作改善。有 1 例(0.4%)患者 30 天或住院期间死亡。10 例(4%)患者发生 SCI,其中 1%(1/79)的患者神经监测正常,10%(9/91)的患者神经监测下降(P=0.02)。发生永久性截瘫 2 例(1%)。与 SCI 相关的因素包括总手术时间(优势比 1.5,95%置信区间 1.1-2.2,P=0.02)和需要 TASP 的神经监测持续变化(优势比 15.7,95%置信区间 2.9-86.2,P=0.001)。
本前瞻性非随机研究采用标准化策略预防 F-BEVAR 中的 SCI,SCI 发生率低。发生永久性截瘫 1%。